Lexapient connects your documents directly to AI. No cloud upload, no middleman, no compromise. Extract, compare, and analyse at scale - from your desktop.
Three core capabilities, one workspace. More coming.
Direct connection from your desktop to Google's API. No proxy, no cloud backend. We couldn't see your data even if we wanted to.
Define extraction rules once. Apply across hundreds of documents in parallel. Get structured results with citations.
Browse local folders, pull emails from Outlook, connect to iManage. No manual uploading required.
Most document AI tools ask you to upload your files to their cloud, process them on their servers, and trust that they won't look. That's a promise.
We built Lexapient so there's
nothing to promise.
Select files from local folders, Outlook inbox, or iManage. PDFs, Word docs, and emails - all supported. Nothing leaves your machine until you say so.
Pick a pre-built template or define your own extraction rules. Each rule specifies what to extract and the answer format - short answer, multiple choice, exact quote, or open answer.
Documents process in parallel. Results appear in an interactive grid with source citations. Sort, filter, mark as reviewed, then export to Excel or Word.
Not by policy. Not by promise. By architecture.
Every API call goes straight from your machine to Google Gemini. No proxy. No intermediary. No man in the middle.
Documents, Playbooks, results, and prompts never leave your machine. LLM responses are held in memory only - never persisted unless you export.
Use our provisioned access or supply your own Gemini API key. Either way, we never see what you process. Your key, your billing, your control.
The app talks to Google's API, our key service, and the update server. Nothing else. Verify it yourself with any network monitor or firewall log.
Other tools lock you into monthly subscriptions whether you use them or not. Lexapient charges only for the tokens your documents consume - down to the last one.
Load documents into a batch
Run extraction - tokens are counted
See exact cost before & after
Lexapient is in active development. Join the waitlist to get early access and help shape the product with your feedback.